Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 1,463 | 473 | 0 | 0 | 0 |
Gross Profit | 1,463 | 473 | N/A | N/A | N/A |
Operating Expenses | 7,709 | 7,280 | 7,622 | 7,937 | 11,459 |
Operating Income | -6,246 | -6,807 | -7,622 | -7,937 | -11,459 |
Other Income | -702 | 4 | -2,379 | -462 | -625 |
Pre-tax Income | -6,948 | -6,803 | -10,001 | -8,399 | -12,084 |
Income Tax | N/A | N/A | N/A | N/A | -999 |
Net Income Continuous | -6,948 | -6,803 | -10,001 | -9,398 | -11,085 |
Net Income Discontinuous | 157 | N/A | 12,898 | 1,224 | 4,161 |
Net Income | $-6,791 | $-6,803 | $2,897 | $-8,174 | $-6,924 |
EPS Basic Total Ops | -92.51 | -92.51 | 39.21 | 3.08 | -94.71 |
EPS Basic Continuous Ops | -94.71 | -92.51 | -134.80 | -21.59 | -151.54 |
EPS Basic Discontinuous Ops | 2.20 | N/A | 173.57 | 24.67 | 56.83 |
EPS Diluted Total Ops | -92.51 | -92.51 | 39.21 | 3.08 | -94.71 |
EPS Diluted Continuous Ops | -94.71 | -92.51 | -134.80 | -21.59 | -151.54 |
EPS Diluted Discontinuous Ops | 2.20 | N/A | 173.57 | 24.67 | 56.83 |
EBITDA(a) | $-5,946 | $-6,498 | $-7,167 | $-7,404 | $-10,913 |